January 10, 2020 / 6:21 AM / 9 days ago

BRIEF-Basilea FY 2019 Total Revenue Expected To Increase To About CHF 134 Mln

Jan 10 (Reuters) - BASILEA PHARMACEUTICA AG:

* BASILEA REPORTS TOTAL REVENUE EXCEEDING GUIDANCE DRIVEN BY HIGHER THAN EXPECTED CONTRIBUTIONS FROM CRESEMBA® AND ZEVTERA® IN 2019

* FY TOTAL REVENUE IS EXPECTED TO INCREASE TO APPROX. CHF 134 MILLION (FYR 2018: CHF 132.6 MILLION) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below